OBJECTIVES: Suppressive antiretroviral therapy (ART) substantially decreases HIV transmission in clinical research settings. We sought to measure the frequency and correlates of periods of transmission risk among individuals taking ART during multiple years of observation in rural, southwestern Uganda. DESIGN: Observational cohort study. METHODS: We collected sexual behavior and viral load data in a Ugandan cohort of people living with HIV/AIDS from the time of ART initiation. We defined each 90-day visit as a potential transmission period if HIV-1 RNA was more than 400 copies/ml and the participant reported sexual transmission risk behavior, defined as unprotected sexual contact with at least 1 HIV-uninfected partners or partners of unknown serostatus in the prior 90 days. RESULTS: We evaluated data from 463 individuals on ART over a median 3.5 years of observation and 5293 total study visits. During that time, over half (259, 56%) had detectable viremia or reported sexual transmission risk behavior at least once. However, only 23 (5%) had both simultaneously, at 28 (<1%) of all visits. Transmission sexual behavior was reported at 6% of visits with detectable viremia. In multivariable regression modeling, correlates of transmission risk periods included younger age, lower CD4 cell count, low household asset ownership and increased internalized stigma. CONCLUSION: Although detectable viremia and/or sexual transmission risk behavior occurred in over half of individuals, ART reduced periods of HIV transmission risk by over 90% during up to 6 years of observation time. These findings provide further support for provision of ART, along with interventions to promote long-term adherence, to reduce HIV transmission in HIV-endemic settings.
OBJECTIVES: Suppressive antiretroviral therapy (ART) substantially decreases HIV transmission in clinical research settings. We sought to measure the frequency and correlates of periods of transmission risk among individuals taking ART during multiple years of observation in rural, southwestern Uganda. DESIGN: Observational cohort study. METHODS: We collected sexual behavior and viral load data in a Ugandan cohort of people living with HIV/AIDS from the time of ART initiation. We defined each 90-day visit as a potential transmission period if HIV-1 RNA was more than 400 copies/ml and the participant reported sexual transmission risk behavior, defined as unprotected sexual contact with at least 1 HIV-uninfected partners or partners of unknown serostatus in the prior 90 days. RESULTS: We evaluated data from 463 individuals on ART over a median 3.5 years of observation and 5293 total study visits. During that time, over half (259, 56%) had detectable viremia or reported sexual transmission risk behavior at least once. However, only 23 (5%) had both simultaneously, at 28 (<1%) of all visits. Transmission sexual behavior was reported at 6% of visits with detectable viremia. In multivariable regression modeling, correlates of transmission risk periods included younger age, lower CD4 cell count, low household asset ownership and increased internalized stigma. CONCLUSION: Although detectable viremia and/or sexual transmission risk behavior occurred in over half of individuals, ART reduced periods of HIV transmission risk by over 90% during up to 6 years of observation time. These findings provide further support for provision of ART, along with interventions to promote long-term adherence, to reduce HIV transmission in HIV-endemic settings.
Authors: Rebecca Bunnell; John Paul Ekwaru; Peter Solberg; Nafuna Wamai; Winnie Bikaako-Kajura; Willy Were; Alex Coutinho; Cheryl Liechty; Elizabeth Madraa; George Rutherford; Jonathan Mermin Journal: AIDS Date: 2006-01-02 Impact factor: 4.177
Authors: Alexander C Tsai; Sheri D Weiser; Wayne T Steward; Nozmo F B Mukiibi; Annet Kawuma; Annet Kembabazi; Conrad Muzoora; Peter W Hunt; Jeffrey N Martin; David R Bangsberg Journal: AIDS Behav Date: 2013-01
Authors: Lance S Rintamaki; Terry C Davis; Silvia Skripkauskas; Charles L Bennett; Michael S Wolf Journal: AIDS Patient Care STDS Date: 2006-05 Impact factor: 5.078
Authors: Elvin H Geng; David R Bangsberg; Nicolas Musinguzi; Nneka Emenyonu; Mwebesa Bosco Bwana; Constantin T Yiannoutsos; David V Glidden; Steven G Deeks; Jeffrey N Martin Journal: J Acquir Immune Defic Syndr Date: 2010-03 Impact factor: 3.731
Authors: Jeffrey W Eaton; Leigh F Johnson; Joshua A Salomon; Till Bärnighausen; Eran Bendavid; Anna Bershteyn; David E Bloom; Valentina Cambiano; Christophe Fraser; Jan A C Hontelez; Salal Humair; Daniel J Klein; Elisa F Long; Andrew N Phillips; Carel Pretorius; John Stover; Edward A Wenger; Brian G Williams; Timothy B Hallett Journal: PLoS Med Date: 2012-07-10 Impact factor: 11.069
Authors: Sae Takada; Viola Nyakato; Akihiro Nishi; A James O'Malley; Bernard Kakuhikire; Jessica M Perkins; David R Bangsberg; Nicholas A Christakis; Alexander C Tsai Journal: Soc Sci Med Date: 2019-05-20 Impact factor: 4.634
Authors: Sae Takada; Sheri D Weiser; Elias Kumbakumba; Conrad Muzoora; Jeffrey N Martin; Peter W Hunt; Jessica E Haberer; Annet Kawuma; David R Bangsberg; Alexander C Tsai Journal: Ann Behav Med Date: 2014-08
Authors: Shada A Rouhani; Kelli N O'Laughlin; Zikama M Faustin; Alexander C Tsai; Julius Kasozi; Norma C Ware Journal: Glob Public Health Date: 2016-01-19
Authors: Mark J Siedner; Courtney K Ng; Ingrid V Bassett; Ingrid T Katz; David R Bangsberg; Alexander C Tsai Journal: Clin Infect Dis Date: 2014-12-16 Impact factor: 9.079
Authors: Lynn T Matthews; Heather B Ribaudo; Angela Kaida; Kara Bennett; Nicholas Musinguzi; Mark J Siedner; Jerome Kabakyenga; Peter W Hunt; Jeffrey N Martin; Yap Boum; Jessica E Haberer; David R Bangsberg Journal: J Acquir Immune Defic Syndr Date: 2016-04-01 Impact factor: 3.731
Authors: Elizabeth F Closson; Matthew J Mimiaga; Susan G Sherman; Arunrat Tangmunkongvorakul; Ruth K Friedman; Mohammed Limbada; Ayana T Moore; Kriengkrai Srithanaviboonchai; Carla A Alves; Sarah Roberts; Catherine E Oldenburg; Vanessa Elharrar; Kenneth H Mayer; Steven A Safren Journal: PLoS One Date: 2015-03-20 Impact factor: 3.240
Authors: Thuc Minh Thi Vu; Victoria L Boggiano; Bach Xuan Tran; Long Hoang Nguyen; Tung Thanh Tran; Carl A Latkin; Cyrus S H Ho; Roger C M Ho Journal: Int J Environ Res Public Health Date: 2018-05-29 Impact factor: 3.390